SCHEMBL17273903

SCHEMBL17273903

O=C(Nc1ccc2c(c1)[nH]c(=O)c1ccccc12)c1ccccc1-c1ccccc1C(=O)O[C@]1([C@H]2Nc3cc(-c4ccccc4)ccc3O2)Nc2cc(-c3ccccc3)ccc2O1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ BRD4 O60885 4/20 0.35
▸ PARP1 P09874 2/20 0.33
▸ CREBBP Q92793 1/20 0.32
▸ TP53 P04637 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ SERPINE1 P05121 1/20 0.31
▸ KDR P35968 1/20 0.30
▸ CFTR P13569 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ AURKA O14965 1/20 0.30
▸ AURKB Q96GD4 1/20 0.30
▸ ROCK2 O75116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17273902 0.81 KMT2A (0.70) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL30625698 0.73 KDM4E (0.83) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL2583091 0.71 CYP2C9 (1.00) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL30516131 0.71 CYP2C9 (1.00) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL22173221 0.57 MAPT (0.68) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL25835280 0.57 ERCC1 (0.50) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL20227594 0.55 PARP1 (0.63) KMT2AKDM4EMEN1CYP1A2PARP1
SCHEMBL21636104 0.55 PARP1 (0.63) KMT2AKDM4EMEN1CYP1A2PARP1
SCHEMBL30625697 0.55 TP53 (0.55) KMT2AKDM4EMEN1CYP1A2CYP3A4
SCHEMBL14933432 0.54 PARP1 (0.62) KMT2AKDM4EMEN1CYP1A2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9879058-B2 Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders UNIVERSIDAD ANDRES BELLO (CL) 2018-01-30 — — US disclosed
US-20150337018-A1 USE OF COMPOUNDS THAT SELECTIVELY MODULATE ASTROCYTIC RELEASE OF SUBSTANCES THROUGH HEMICHANNELS OF CONNEXINS AND PANNEXINS, WITHOUT INFLUENCING GAP JUNCTIONS, FOR THE TREATMENT OF PSYCHIATRIC DISORDERS UNIVERSIDAD ANDRES BELLO (CL) 2015-11-26 — — US disclosed
Send feedback